Free Trial
Ryland Conrad

Ryland Conrad Analyst Performance

Equity Research Analyst at Royal Bank Of Canada

Ryland Conrad is a stock analyst at Royal Bank Of Canada across a range of sectors, covering 2 publicly traded companies. Over the past year, Ryland Conrad has issued 3 stock ratings, including buy and hold recommendations. While full access to Ryland Conrad's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ryland Conrad's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
3 Last 0 Years
Buy Recommendations
66.67% 2 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%2 ratings
Hold33.3%1 ratings
Sell0.0%0 ratings

Out of 3 total stock ratings issued by Ryland Conrad at Royal Bank Of Canada, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
100.0% of companies on NYSE
2 companies

Ryland Conrad, an analyst at Royal Bank Of Canada, currently covers 2 companies listed on , with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Consumer Discretionary
1 company
50.0%
Medical
1 company
50.0%

Ryland Conrad of Royal Bank Of Canada specializes in stock coverage within the Consumer Discretionary sector, with additional focus on Medical companies.

Coverage Industries

IndustryPercentage
TEXTILE - APPAREL
1 company
50.0%
MED PRODUCTS
1 company
50.0%

Ryland Conrad's Ratings History at Royal Bank Of Canada

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Gildan Activewear, Inc. stock logo
GIL
Gildan Activewear
8/14/2025Boost Price Target$56.49$68.00Outperform
Gildan Activewear, Inc. stock logo
GIL
Gildan Activewear
8/5/2025Initiated Coverage$52.00$61.00Outperform
Prestige Consumer Healthcare Inc. stock logo
PBH
Prestige Consumer Healthcare
3/21/2025Boost Price Target$84.44$97.00Sector Perform